Survival following coronary angioplasty versus coronary artery bypass surgery in anatomic subsets in which coronary artery bypass surgery improves survival compared with medical therapy
Results from the Bypass Angioplasty Revascularization Investigation (BARI)
Peter B. Berger, MD, FACC*,*,
James L. Velianou, MD*,
Helen Aslanidou Vlachos, MSc ,
Frederick Feit, MD, FACC ,
Alice K. Jacobs, MD, FACC ,
David P. Faxon, MD, FACC||,
Michael Attubato, MD, FACC,
Norma Keller, MD, FACC,
Michael L. Stadius, MD, FACC¶,
Bonnie H. Weiner, MD, FACC#,
David O. Williams, MD, FACC**,
Katherine M. Detre, MD, DrPH on behalf of the BARI Investigators
* Division of Cardiovascular Disease, Mayo Clinic, Rochester, Minnesota, USA
University of Pittsburgh, Pittsburgh, Pennsylvania, USA
NYU Medical Center, New York, New York, USA
Boston Medical Center, Boston, Massachusetts, USA
|| University of Chicago, Chicago, Illinois, USA
¶ Seattle Veterans Administration Hospital, Seattle, Washington, USA
# University of Massachusetts Medical Center, Worcester, Massachusetts, USA
** Brown University/Rhode Island Hospital, Providence, Rhode Island, USA
View larger version (15K):
[in a new window]
|
Figure 1 Survival curves of patients with three-vessel disease in the Bypass Angioplasty Revascularization Investigation undergoing percutaneous transluminal coronary angioplasty (PTCA) and coronary artery bypass graft (CABG).
|
|
View larger version (14K):
[in a new window]
|
Figure 2 Survival curves of patients with three-vessel disease and reduced ventricular function undergoing percutaneous transluminal coronary angioplasty (PTCA) and coronary artery bypass graft (CABG) in the Bypass Angioplasty Revascularization Investigation.
|
|
View larger version (15K):
[in a new window]
|
Figure 3 Survival curves of nondiabetic patients with three-vessel disease reveal no difference in survival between the percutaneous transluminal coronary angioplasty (PTCA) and coronary artery bypass graft (CABG) groups at seven years.
|
|
View larger version (15K):
[in a new window]
|
Figure 4 Survival of non-diabetic patients with three-vessel disease and reduced ventricular function. CABG = coronary artery bypass graft; PTCA = percutaneous transluminal coronary angioplasty.
|
|
View larger version (14K):
[in a new window]
|
Figure 5 Survival of all patients with two-vessel disease including the proximal left anterior descending artery. Abbreviations as in Figure 4.
|
|
View larger version (14K):
[in a new window]
|
Figure 6 Survival of all patients with two-vessel disease including the proximal left anterior descending artery and reduced ventricular function. Abbreviations as in Figure 4.
|
|
View larger version (15K):
[in a new window]
|
Figure 7 Survival of non-diabetic patients with two-vessel disease including the proximal left anterior descending artery. Abbreviations as in Figure 4.
|
|
View larger version (14K):
[in a new window]
|
Figure 8 Survival of non-diabetic patients with two-vessel disease including the proximal left anterior descending artery and reduced ventricular function. Abbreviations as in Figure 4.
|
|
|
